Press release
AI-Driven Precision Medicine Market to Reach USD 9.7 Billion by 2035, Powered by Machine Learning, Multi-omics and Real-time Clinical AI
AI-Driven Precision Medicine Market to Reach USD 9.7 Billion by 2035, Powered by Machine Learning, Multi-omics and Real-time Clini
Rapid advances in machine-learning models for genomics and imaging, multi-omics analytics, and clinical-grade AI devices are enabling earlier detection, faster treatment matching, and workflow automation that together compress diagnostic timelines and improve therapeutic precision.
MarketGenics, a leading research firm, highlights the AI-driven precision medicine sector as a critical enabler of personalized care and clinical decisioning in an era of rising chronic disease burden and accelerating multi-modal data generation.
Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the AI-Driven Precision Medicine Market Research Report: https://marketgenics.co/press-releases/ai-driven-precision-medicine-market-41168
Recent Developments Shaping the Market
Tempus One - portability for precision oncology
In April 2025, Tempus AI launched Tempus One, a portable AI device aimed at delivering cost-effective, point-of-care precision oncology recommendations by integrating genomic and clinical data into the clinician workflow.
PathAI - clinical pathology scale-up
PathAI has expanded deployments with major clinical partners to roll out AI-enabled pathology models for real-time cancer diagnosis and staging, improving diagnostic consistency and throughput across hospital networks.
Multi-omics screening progress
AI-powered multi-omics programs continue to advance early cancer detection workflows by combining genomic, proteomic and other molecular signals into predictive models that enhance screening and trial enrichment.
Market Forecast 2035
The market is set to create an incremental opportunity of USD 9.0 billion between 2025 and 2035.
North America will remain the largest and most mature market, driven by genomics capacity, clinical validation networks, and early clinical AI adoption.
Asia-Pacific will register the fastest growth as genomics infrastructure and digital health programs scale.
Europe will grow steadily, guided by emphasis on clinical validation, explainability and regulatory alignment.
By 2035, AI will be embedded into diagnostic pipelines, trial enrichment and treatment-selection workflows across major therapeutic areas.
To know more about the AI-Driven Precision Medicine Market - Download our Sample Report: https://marketgenics.co/download-report-sample/ai-driven-precision-medicine-market-41168
Key Drivers, Challenges, and Opportunities
Driver - Machine-learning enabled decisioning
ML models improve biomarker discovery, patient stratification and response prediction, reducing empirical "trial-and-error" therapy choices and improving matched-therapy rates.
Restraint - Data, validation and regulatory overhead
High-quality multi-modal data, formal clinical validation, and regulatory clearance remain resource-intensive requirements that lengthen commercialization timelines.
Opportunity - Real-time clinical AI at the edge
Portable and integrated AI solutions that operate at the point-of-care or as on-prem EHR agents expand access to precision recommendations across community hospitals and lower-resource sites.
Key Trend - Clinicalization of AI: from models to medical devices
The sector is shifting from research prototypes to regulated, clinical-grade software and appliances. Winning solutions will combine clinical evidence, explainability tooling, seamless EHR integration, and measurable outcome benefits that support reimbursement and clinician adoption.
Buy Now: https://marketgenics.co/buy/ai-driven-precision-medicine-market-41168
Segmental Insights
Technology: Machine Learning leads with ~39% share (2025) - ML's versatility across genomics, predictive analytics and imaging makes it the dominant technology. Deep learning and computer vision drive histopathology and radiology automation; NLP unlocks unstructured EHR value.
Applications: Early cancer detection, treatment optimization, and pathology/cellular analysis are the highest-value use cases today.
Delivery: On-prem/portable appliances and cloud-hybrid models coexist - portability enables broader clinical reach while cloud backends enable large-scale model training.
Regional Highlights
North America: Largest market - clinical validation ecosystems, oncology programs, and commercialization pathways support rapid uptake.
Asia-Pacific: Fastest growth - expanding genomics capacity and health system digitization.
Europe: Emphasis on clinical validation, explainability and regulatory alignment.
Competitive Landscape
The market is moderately fragmented with platform scale and clinical validation as key advantages. Notable organizations active in this space include NVIDIA, Google Health/DeepMind, Microsoft Healthcare, IBM Watson Health, Tempus Labs, PathAI, Freenome, Guardant Health, and Roche (Flatiron/Foundation Medicine). Competition centers on data assets, regulatory clearance, clinician trust, and the ability to demonstrate outcome-linked value.
Get a preview of our AI-Driven Precision Medicine Market Playbook - your guide to GTM strategy, competitive intelligence, supplier dynamics, and Consumer Behavior Analysis: https://marketgenics.co/playbook/ai-driven-precision-medicine-market-41168
Future Outlook
By 2035, AI-driven precision medicine will be a routine clinical capability in oncology and select chronic diseases: real-time decision support, multi-omics screening, and AI-assisted pathology will shorten diagnostic loops and improve matched-therapy rates.
The decade ahead will reward vendors who pair clinical evidence with practical integration and explainable AI that clinicians and payers can rely on.
Prominent Companies Operating in the AI-Driven Precision Medicine Market
NVIDIA, Google Health/DeepMind, Microsoft Healthcare, IBM Watson Health, Tempus Labs, PathAI, Freenome, Guardant Health, Roche (Flatiron/Foundation Medicine), and other specialized innovators.
About Us
MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.
We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.
Contact:
Mr. Debashish Roy
MarketGenics India Pvt. Ltd.
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI-Driven Precision Medicine Market to Reach USD 9.7 Billion by 2035, Powered by Machine Learning, Multi-omics and Real-time Clinical AI here
News-ID: 4205315 • Views: …
More Releases from MarketGenics India Pvt. Ltd.
3D Bioprinting Market for Tissues & Organs to Reach USD 6 Billion by 2035, Drive …
The global 3D bioprinting market for tissues and organs is projected to grow from USD 1.4 billion in 2025 to USD 6.0 billion by 2035, expanding at a CAGR of 14.1% during the forecast period.
Growth is fueled by increasing demand for organ transplants, advances in regenerative medicine, and adoption of bioprinted models for pharmaceutical testing.
MarketGenics highlights 3D bioprinting as a transformative enabler in healthcare, offering alternatives to donor shortages,…
Anti-Aging Products Market to Reach USD 112.3 Billion by 2035, Fueled by AI-Driv …
The global Anti-Aging Products Market is projected to grow from USD 51.7 billion in 2025 to USD 112.3 billion by 2035, expanding at a CAGR of 7.3% over the forecast period.
Growth is driven by rising demand for personalized skincare, clean-label and bioactive ingredients, and digital-first product models (AI diagnostics + D2C subscriptions) that improve engagement and lifetime value.
MarketGenics positions anti-aging solutions as a cross-sector growth engine-where cosmetics, supplements, diagnostics,…
Antifungal Drugs Market to Reach USD 21.2 Billion by 2035, Driven by Novel Class …
The global Antifungal Drugs Market is projected to grow from USD 14.3 billion in 2025 to approximately USD 21.2 billion by 2035, expanding at a CAGR of 4.0% over the forecast period.
This steady growth is being driven by the emergence of novel antifungal classes targeting resistant molds, the shift toward once-weekly and oral step-down regimens, and increasing integration of rapid diagnostics with therapeutic stewardship to improve outcomes and limit…
Bioelectric Toothbrush Market to Reach USD 2.1 Billion by 2035, Driven by Ionic …
The global Bioelectric Toothbrush Market is projected to grow from USD 0.7 billion in 2025 to USD 2.1 billion by 2035, expanding at a CAGR of 11.3% during the forecast period. Growth is powered by rising oral-health awareness, broader adoption of ionic and microcurrent technologies, and the integration of AI-guided brushing and app connectivity that together elevate routine hygiene into therapeutic, data-driven care.
MarketGenics, a specialist market research firm, positions bioelectric…
More Releases for Medicine
Empowering Medicine through Student Nonprofit: Medicine Community & Research
Image: https://www.abnewswire.com/uploads/be780e491a4ae6bc377728149d5124cc.png
(MCR's Logo by Jason Jiang)
Many students dream of leading thousands and creating an impact in their community.
Among these are Quang La (Founder), Adhrith (Co-founder), and Heymin Han (Co-founder) who came together to create Medicine Community & Research, a 501c3 nonprofit organization fiscally sponsored by The Hack Foundation.
The mission of MCR revolves around 3 key things, a student community, a spread of medicine articles, and an organization that advocates for…
Chinese Medicine Pot Market: Traditional Herbal Medicine Preparation and Brewing …
Global Chinese Medicine Pot Market Overview:
The Chinese Medicine Pot market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Chinese Medicine Pot market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…
Herbal Medicine Market 2019-2025: Market By Development, Regional Sales, Regiona …
In a recent study published by QY Research, titled Herbal Medicine, analysts offers an in-depth analysis of global Herbal Medicine market. The study analyses the various aspect of the market by studying its historic and forecast data. The research report provides Porters five force model, SWOT analysis, and PESTEL analysis of the market. The different areas covered in the report are market size, drivers and restrains, segment analysis, geographic outlook,…
Tropical Medicine
Tropics are the most diverse regions on the earth . A large number of population live in this region where the weather varies throughout the year ( from scorching summer to chilly winter).This changing seasons induce the outbreaks of some fetal diseases known as tropical diseases which is unique only to the tropical areas.
Malaria, Tuberculosis & AIDS are the major ones .Lack of sanitation, personal hygiene, proper…
Sports Medicine Market 2018 | Top Most Players | Medstar Sports Medicine, Muelle …
Competitive Insights:
The Sports Medicine Market is dominated by a few large players such as Arthrex, Inc, Smith & Nephew, DePuy Mitek Inc, and Stryker Corporation, who have consolidated the market controlling a share of more than 70% in 2016. These players consistently introduce innovative and technologically advanced products in the market to ensure a competitive advantage over the other players. Some other players operating in this industry are Medstar Sports…
Indian Medicine
Dr.JRK's Siddha Research and Pharma is the herbal medicine in India, and has been in the business of good manufacturing practices. We strongly believing in intellectual asset creation through discovery, documentation and development of Indian systems of medicine. G7 capsules is the solution for Allergic Disorders the herbal medicine in Inida. Atopy or hyper sensitivity is the major problem in all countries, the problem manifest in multifold ways such as…
